VISA PHARMA
ActiveSummary
VISA PHARMA has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €185,093 and a net result of €123,381. Equity is growing by about 44% per year across the filed financial years. Its solvency ranks better than 43% of 12,678 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
26-08
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format · 26 days late
2025
31-12
Financial
Highest result from 2018 to 2025net €123,381 ▲1.2%
Operating result €170,863, net result €123,381, both a record.
31-12
Financial
Equity above €150,000equity €185,093 ▲49.6%
5 profitable years in a row build equity to €185,093.
29-08
NBB filing
Annual accounts filed
financial year 2024 · full format · 29 days late
2024
31-12
Financial
Equity above €100,000equity €123,712 ▲139%
4 profitable years in a row build equity to €123,712.
29-08
NBB filing
Annual accounts filed
financial year 2023 · full format · 29 days late
2023
11-10
NBB filing
Annual accounts filed
financial year 2022 · full format · 72 days late
11-09
Gazette deed
Resignation: PHARMACIE SABRINE ELSEN (manager)Permanent representative: ELSEN Sabrine · Appointment: MANAGEMENT SABRINE ELSEN (director) · Amendment of the articles13 facts ▸
Gazette deed
Resignation: PHARMACIE SABRINE ELSEN (manager)
Permanent representative: ELSEN Sabrine · Appointment: MANAGEMENT SABRINE ELSEN (director) · Amendment of the articles13 facts ▸
- General meeting, 07-09-2023
- Amendment of the articles (2 times)
- Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
- Other provision, “totalité capital libérée, absence compte apports non appelés” (deed in French)
- Reserve release, “disponible pour distribution, formes et majorités modification statuts” (deed in French)
- Capital
- Other provision, “droit commun, application des règles déontologiques” (deed in French)
- Director resignation, PHARMACIE SABRINE ELSEN (manager)
- Permanent representative, ELSEN Sabrine (2 times)
- Director appointment, MANAGEMENT SABRINE ELSEN (director (not named in the articles))
- Registered office clause, “unanimité, 4052 Beaufays (Chaudfontaine), Place de la Bouxhe 10” (deed in French)
- Power of attorney
- +1 further fact in this act
2022
23-08
NBB filing
Annual accounts filed
financial year 2021 · full format · 23 days late
2021
31-12
Financial
Back to profitnet €60,797
Net result €60,797 after one loss-making year.
31-08
NBB filing
Annual accounts filed
financial year 2020 · full format · 31 days late
2020
08-10
NBB filing
Annual accounts filed
financial year 2019 · full format · 69 days late
Show earlier events
2019
31-12
Financial
Back to profitnet €19,508
Net result €19,508 after one loss-making year.
31-08
NBB filing
Annual accounts filed
financial year 2018 · full format · 31 days late
2018
31-08
NBB filing
Annual accounts filed
financial year 2017 · full format · 31 days late
2017
31-08
NBB filing
Annual accounts filed
financial year 2016 · full format · 31 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 13 annual accounts filed, the latest 10 are here; all 13 are under Financials.
1 of 4 deeds read
About the unread acts
Of the 4 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.